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a b s t r a c t
Heme oxygenase-1 (HO-1) is an important anti-inﬂammatory, antioxidative and cytoprotective enzyme that
is regulated by the activation of the major transcription factor, nuclear factor (erythroid-derived 2)-like 2
(Nrf2). In the present study, six stilbene derivatives isolated from Rheum undulatum L. were assessed for their
antioxidative potential. In the tert-butylhydroperoxide (t-BHP)-induced RAW 264.7 macrophage cell line,
desoxyrhapontigenin was the most potent component that reduced intracellular reactive oxygen species
(ROS) and peroxynitrite. In response to desoxyrhapontigenin, the mRNA expression levels of antioxidant
enzymes were up-regulated. An electrophoretic mobility shift assay (EMSA) conﬁrmed that desoxyrhapon-
tigenin promoted the DNA binding of Nrf2 and increased the expression of antioxidant proteins and enzymes
regulated by Nrf2. Further investigation utilizing speciﬁc inhibitors of Akt, p38, JNK and ERK demonstrated
that the phosphatidylinositol 3-kinase (PI3K)/Akt pathway mediates HO-1 expression. Moreover, the increase
in Nrf2 expression mediated by treatment with desoxyrhapontigenin was reversed by Nrf2 or Akt gene
knock-down. In the LPS-induced in vivo lung inﬂammation model, pretreatment with desoxyrhapontigenin
markedly ameliorated LPS-induced lung inﬂammation and histological changes. Immunohistochemical
analysis of Nrf2, HO-1 and p65 was conducted and conﬁrmed that treatment with desoxyrhapontigenin
induced Nrf2 and HO-1 expression but reduced p65 expression. These ﬁndings suggest that desoxyrha-
pontigenin may be a potential therapeutic candidate as an antioxidant or an anti-inﬂammatory agent.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcrip-
tion factor that is encoded by the NFE2L2 gene in humans [1]. The
function of Nrf2 and its downstream target antioxidant genes have
been shown to be important for cytoprotection against reactive
oxygen species (ROS), reactive nitrogen species (RNS) and cellular
damage [2]. Nrf2 is constitutively located in the cytoplasm and
bound to Kelch-like ECH-associated protein 1 (Keap1), also known
as the Nrf2 repressor. The activation of Nrf2 is primarily controlled
by Keap1, which constantly ubiquitylates Nrf2 and leads to its
degradation in the cytoplasm. In response to oxidative stress, Nrf2 is
released from Keap1, translocates into the nucleus, forms a hetero-
dimer with the small Maf protein and binds to antioxidant-related
elements (ARE) in the promoter region of phase II detoxifying
enzymes and cytoprotective genes [3]. These enzymes include NAD
(P)H quinone oxidoreductase (NQO1), glutathione S-transferase (GST),
heme oxygenase-1 (HO-1), glutathione peroxidase (GPx), glutamate
cysteine ligase (GCL) and peroxiredoxin I (Prx I) [4].
HO-1 is the major anti-inﬂammatory and cytoprotective enzyme
among the genes that are regulated by Nrf2 activation [5]. HO is an
enzyme that catalyzes the degradation of heme to produce biliverdin,
iron and carbon monoxide (CO). The various biochemical actions of
heme degradation products and their metabolic derivatives contri-
bute to the cytoprotective functions of HO-1. Three isoforms of heme
oxygenase exist but only HO-1 is induced in response to stress. HO-1
expression is up-regulated in response to various forms of inﬂam-
matory stimuli, and this up-regulation is associated with its anti-
inﬂammatory actions. HO-1 has critical roles in both biosynthesis
and degradation pathways of heme. When HO-1 catalyzes heme to
biliverdin and bilirubin, these degradation products have antioxidant
properties. Iron, which is degraded from heme, may also contribute
to cytoprotective properties against oxidative stress or inﬂammation
by the stimulation of ferritin synthesis followed by iron detoxiﬁca-
tion [6,7]. Mice with HO-1 deﬁciency have a distinct phenotype with
an increased inﬂammatory state, suggesting that HO-1 is critical for
the resolution of inﬂammation [8].
The interaction between Nrf2 and NF-κB is interesting because
numerous phytochemicals that have anti-inﬂammatory, antioxidative
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or anti-cancer properties suppress NF-κB signaling and activate the
Nrf2 pathway [9]. Jin et al. reported that Nrf2-deﬁcient mice with head
injury showed a higher cerebral NF-κB activation than wild-type mice
[10]. The mitogen-activated protein kinase (MAPK) family contributes
to both the Nrf2 and NF-κB pathways. NF-κB competes with Nrf2 for
binding to the transcriptional coactivator CREB-binding protein (CBP)
and also promotes the binding of the corepressor histone deacetylase
3 (HDAC3) to ARE. Thus, NF-κBmay be a negative regulator of the Nrf2
pathway [11].
This study investigated the biological activities of isolated com-
ponents from the rhubarb plant. Because rhubarb is known to have
anti-inﬂammatory properties, it has the potential to exhibit diverse
biological activities. Stilbene compounds are primarily present in
grapes and red wine, but Rheum undulatum L. is also known to
contain a number of stilbene derivatives. Moreover, resveratrol is a
well-known phytochemical that possesses various biological proper-
ties, including anticancer, antiviral, anti-inﬂammatory and antioxi-
dant activities [12–14]. Its extract and fractions showed apoptotic
effect on oral cancer cells and killed bacteria which are involved in
dental diseases [15–17]. Furthermore, R. undulatum showed potent
inhibitory effects on diabetes and obesity due to its major compo-
nents anthraquinones as well as stilbene derivatives [18,19]. Phar-
macokinetic study of major compounds present in this plant has
been also carried out [20,21]. Anti-inﬂammatory potentials of stil-
bene components isolated from R. undulatum have been recently
studied and published [22]. However, R. undulatum L. cannot be used
as an herbal medicine in Korea, because it is not listed in the Korean
Pharmacopeia and does not contain sennoside A which is a marker
component. However, the use of R. undulatum L. needs to be
encouraged because, although it lacks sennoside A, it has sufﬁcient
amounts of anthraquinones as well as stilbenes. Several research
groups studying stilbene analogs found that stilbenes are valuable
chemicals [23–25]. Thus, the presence of the stilbene derivatives in R.
undulatum L. is distinctly noteworthy. In this report, six stilbene
derivatives isolated from R. undulatum L. were studied including
resveratrol, a well-known bioactive compound and others with
similar structures.
Material and methods
Plant material
The cultivated rhubarb rhizome was purchased at a local herbal
market in Daejeon, Korea in July 2006 and was identiﬁed by
Professor KiHwan Bae. A voucher specimen (CNU-1345) was
deposited in the herbarium of College of Pharmacy at Chungnam
National University in Korea. Furthermore, the chemical-based
species classiﬁcation has been conducted to identify rhubarb
species [26].
Isolation of stilbene derivatives
The dried and milled rhizomes of rhubarb (4.7 kg) were
extracted three times with 20 L of 70% ethanol. The ethanol extracts
were combined and concentrated, and the residue (650 g) was used
to isolate rhaponticin (1), rhapontigenin (2), isorhaponticin (3),
desoxyrhaponticin (4), desoxyrhapontigenin (5), and resveratrol (6)
as described in a previous report [27]. The structures of the stilbene
derivatives are shown in Fig. 1.
Cell culture
The RAW 264.7 murine macrophages were obtained from the
American Type Culture Collection (Manassas, VA, USA). These
cells were maintained at sub-conﬂuence in a 95% air and 5%
CO2-humidiﬁed atmosphere at 37 1C. DMEM supplemented with
10% fetal bovine serum (FBS), 100 U/mL of penicillin and 100 μg/
mL of streptomycin was used for routine subculturing and in vitro
experiments (GenDEPOT, Barker, TX, USA). Unless otherwise indi-
cated, all of the chemicals that were used in the current study
were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). All of
the samples were dissolved in dimethyl sulfoxide (DMSO), and the
ﬁnal DMSO concentrations were o0.1%.
Cell viability
The measurements of cell viability after exposure to the
stilbene derivatives were performed using an MTT ((4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay.
Brieﬂy, RAW 264.7 cells were plated at a density of 1104 cells
per well in a 96-well plate and incubated at 37 1C for 24 h. The
cells were treated with various concentrations of each stilbene
compound or the vehicle alone and incubated at 37 1C for an
additional 24 h. After the incubation for 24 h, the medium was
removed, and 100 μL of MTT (0.5 mg/mL in DPBS) solution was
added into each well, and the cells were incubated in the same
conditions for an additional 2 h. MTT is cleaved by living cells into
visible formazan crystals during this incubation. The formazan
crystals were then solubilized in DMSO, and the resulting absor-
bance was measured at 595 nm using an enzyme-linked immu-
nosorbent assay (Molecular Devices, Sunnyvale, CA, USA). The
relative cell viability was calculated and compared with the
absorbance of the untreated control group.
Intracellular ROS and peroxynitrite
The intracellular ROS scavenging activity of silbene derivatives
was measured using the oxidant-sensitive ﬂuorescent probe,
DCFH-DA [28]. DCFH-DA is converted to DCFH by deacetylases
within the cells and is oxidized by a variety of intracellular ROS to
the ﬂuorescent compound DCF. RAW 264.7 cells were seeded in a
black 96-well plate. After 24 h, the cells were treated with the
indicated concentrations of stilbenes for 2 h and were incubated
Fig. 1. The structures of the stilbene derivatives that were assessed in this study,
Rhaponticin (1), rhapontigenin (2), isorhaponticin (3), desoxyrhaponticin (4),
desoxyrhapontigenin (5) and resveratrol (6) were studied.
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for 1 h with t-BHP (200 μM) to induce ROS generation. After the
cells were incubated with DCFH-DA (20 μM) for 30 min, the
ﬂuorescence intensity was scanned by a 96-well microplate
ﬂuorometer (Molecular Devices Gemini XS, Sunnyvale, CA, USA)
at an excitation wavelength of 485 nm and an emission wave-
length of 538 nm.
Peroxynitrite scavenging was measured by monitoring the
oxidation of dihydrorhodamine 123 (DHR 123) as described in a
previous report with some modiﬁcations [29]. Brieﬂy, RAW 264.7
cells were seeded in a black 96-well plate and incubated for 24 h.
The indicated concentrations of the stilbene derivatives were
added, and the cells were incubated for 2 h. Subsequently t-BHP
(200 μM) was added to induce peroxynitrite generation, and the
cells were further incubated for 1 h. Rhodamine solution (50 mM
sodium phosphate buffer, 90 mM sodium chloride, 5 mM potas-
sium chloride, 5 mM diethylenetriaminepentaacetic acid (DTPA)
and DHR 123) was then added and incubated with the cells for
another 1 h. The ﬁnal ﬂuorescence intensity was measured on a
microplate ﬂuorometer (Molecular Devices Gemini XS, Sunnyvale,
CA, USA) with excitation and emission wavelengths of 485 nm and
538 nm, respectively.
Western immunoblot analysis
Nuclear and cytoplasmic protein extracts from RAW 264.7 cells
were prepared after treatment with 50 μMof desoxyrhapontigenin for
the indicated time periods. Total protein extracts from the speciﬁed
time periods were also prepared for the detection of Keap1, an
inhibitor of Nrf2. To elucidate the upstream signaling pathway
involved in desoxyrhapontigenin-mediated Nrf2 activation and HO-1
induction, speciﬁc inhibitors of PI3K/Akt (LY294002, BioVision, Milpi-
tas, CA, USA), p38 (SB202190), JNK (SP600125) and ERK (U0126) were
used. Protein extracts were separated by 10% SDS-PAGE, electro-
transferred to nitrocellulose membranes (Whatman GmbH, Dassel,
Germany), blotted with each primary antibody (1:1000) and the
corresponding secondary antibody (1:5000), and detected with the
WEST-ZOLs (plus) Western Detection System (iNtRON, Korea). The
target bands were quantiﬁed using the UN-SCAN-IT™ gel 6.1 software
(Silk Scientiﬁc Corp, Orem, UT, USA).
Quantitative real-time reverse transcriptase polymerase chain
reaction
Total RNA (1 μg) was converted to cDNA by PCR (Genius
FGEN05TD, Teche, England) using the iScriptTM cDNA Synthesis Kit
(BIO-RAD, Hercules, CA, USA) under the following conditions: 25 1C
for 5 min, 42 1C for 30 min and 85 1C for 5 min. Quantitative real-
time reverse-transcription polymerase chain reaction (RT-PCR) ana-
lysis was performed using the Applied Biosystems 7300 real-time
PCR system and software (Applied Biosystems, Carlsbad, CA, USA).
Quantitative PCR was conducted in 0.2 mL PCR tubes with forward
and reverse primers and the SYBR green working solution (iTaq™
Universal SYBR Green Supermix, BIO-RAD, Hercules, CA, USA), using
a custom PCR master mix with the following conditions: 95 1C for
30 s, followed by 40 cycles of 95 1C for 15 s, 55, 58 or 68 1C for 20 s
and 72 1C for 35 s (ampliﬁcation temperature for each gene is
indicated in Table 1). The melting point, optimal conditions and the
speciﬁcity of the reactionwere ﬁrst determined. The sequences of the
PCR primers were previously described [30–32]. The copy number of
each transcript was calculated as the relative copy number normal-
ized to the β-actin copy number.
Electrophoretic mobility shift assay
To assess the activation of Nrf2, an electrophoretic mobility
shift assay (EMSA) was performed as previously described with
some modiﬁcations [33]. RAW 264.7 cells were seeded at a density
of 1106 cells per well in 6-well plates and incubated at 37 1C for
24 h. Subsequently, the cells were incubated with desoxyrhapon-
tigenin for the indicated time points. The nuclear extracts pre-
pared from the cells were incubated with a 32P-end-labeled
22-mer double-stranded Nrf2 consensus oligonucleotide (Santa
Cruz Biotechnology Inc, Santa Cruz, CA, USA: sequences: 5'-TGG
GGA ACC TGT GCT GAG TCA CTG GAG-3' and 3'-ACC CCT TGG ACA
CGA CTC AGT GAC CTC-5') for 30 min at room temperature, and
the DNA-protein complexes were separated from the free oligo-
nucleotides on 6% native polyacrylamide gels. The gels were dried
and visualized using a BAS-1500 apparatus (Fuji, Tokyo, Japan).
Transient transfection of small RNA interference (siRNA)
RAW 264.7 cells were seeded at a density of 3105 cells/well in
6-well plates and allowed to reach approximately 50% conﬂuence
on the day of transfection. The cells were transfected with 50 nM of
scrambled siRNA, Nrf2 siRNA or Akt siRNA using Lipofectamine
RNAiMAX (Invitrogen, Life technologies, CA, USA). After 4 h incuba-
tion, the medium was replaced with fresh medium with FBS.
Production of LPS-treated mice
Five ICR male mice per each group were used for the acute lung
inﬂammation model according to previous report with some
modiﬁcations [34]. Desoxyrhapontigenin (2.5 and 10 mg/kg) was
intraperitoneally administered to mice every other day for one
week. On the seventh day, 5 mg/kg of LPS (E. coli-026:B6, Sigma)
was injected intraperitoneally. Subsequently, the mice were sacri-
ﬁced after 24 h of monitoring, and the lung tissues were excised.
The lung tissues were ﬁxed in 10% formalin, dehydrated with a
gradient of ethanol and embedded in parafﬁn. Tissue sections
(4 μm) were then dewaxed and rehydrated according to a stan-
dard protocol. For histologic analysis, the sections were stained
with hematoxylin and eosin (H&E). For immunohistochemical
analysis of Nrf2, HO-1 and p65, the sections were treated with
1% hydrogen peroxide for 10 min and rinsed with PBS after
deparafﬁnization. Then, sections were blocked with 2% normal
blocking serum in PBS at room temperature for 60 min, followed
by incubation with Nrf2, HO-1 or p65 antibodies. Sections were
analyzed using an inverted microscope (Olympus CKX41, Japan).
Then, the sections were further analyzed and quantiﬁed by the
ImageJ version1.46r software (Wayne Rasband, NIH, USA).
Molecular docking study
The molecular docking study was performed with LigandFit
(Accelrys Inc., CA, USA), which uses a shape-based method for
accurately predicting binding poses within the receptor active site.
The crystal structure of human KEAP1 (PDB code: 1ZGK) was used in
the molecular modeling study. The candidate poses were minimized
in the context of the active site using a grid-based method for
Table 1
The sequences of the PCR primers and ampliﬁcation temperature.
Genes Forward primer Reverse primer ˚C
β-actin CCCACTCCTAAGAGGAGGATG AGGGAGACCAAAGCCTTCAT 55
HO-1 CACGCATATACCCGCTACCT CCAGAGTGTTCATTCGAGA 58
SOD2 GCGGTCGTGTAAACCTCAT CCAGAGCCTCGTGGTACTTC 58
SOD3 CTGAGGACTTCCCAGTGAC GGTGAGGGTGTCAGAGTGT 58
NQO1 TTCTCTGGCCGATTCAGAGT GGCTGCTTGGAGCAAAATG 58
GR CAACACAGTGGCCATTCAC TTGTTTCTCATGGACCACCA 58
GCLS TGGAGCAGCTGTATCAGTG AGAGCAGTTCTTTCGGGT 58
Prx-1 CACTGACAAACATGGGGAAGT TTTGCTCTTTTGGACATCAGG 68
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evaluating protein–ligand interaction energies. The simulation results
were analyzed with Discovery Studio (Accelrys Inc., CA, USA) [35].
Data analysis
The results are expressed as the means7standard deviation
(S.D.). Analysis of variance (ANOVA) with Dunnett's t-test was used
for the statistical analysis of multiple comparisons. P-values less
than 0.05 were considered statistically signiﬁcant. [nPo0.05;
nnPo0.01; nnnPo0.001].
Results
Cell viability
To evaluate cell viability during the experimental treatments in
this study, an MTT assay was conducted under the conditions that
were identical to those used for the treatments. The cell viability
percentages of RAW 264.7 macrophages are shown in Fig. 2A. In
viable cells, mitochondrial succinate dehydrogenase converts MTT
into visible formazan crystals that can be measured by O.D. values
at 595 nm. Incubation with 10, 30, 50 or 100 mM of ﬁve stilbene
derivatives (1–5) for 24 h showed no signiﬁcant change in cell
viability compared to the vehicle-treated cells (Cont). However,
treatment with resveratrol produced signiﬁcant differences in cell
viability at doses of 50 and 100 mM.
Effects of stilbene derivatives on intracellular ROS and peroxynitrite
The effects of stilbene compounds on t-BHP-induced ROS and
peroxynitrite generation in RAW 264.7 cells were evaluated (Fig. 2B
and C). Incubation with t-BHP elevated intracellular ROS and perox-
ynitrite levels that were represented by ﬂuorescence intensity.
Desoxyrhapontigenin and resveratrol displayed dose-dependent
inhibitory effects on t-BHP-induced ROS and peroxynitrite levels.
The half maximal inhibitory concentration (IC50) values of desoxyr-
hapontgenin against ROS and peroxynitrite were 32.83 μM and
28.22 μM, respectively. Resvereatrol showed IC50 values of
49.07 μM for ROS and 37.82 μM for peroxynitrite in t-BHP-induced
RAW 264.7 macrophages.
Effects of desoxyrhapontigenin on the mRNA expression of
antioxidant enzymes and the protein expression of HO-1
Real-time PCR analysis was performed to determine which of
the phase II enzymes are induced by desoxyrhapontigenin. Activa-
tion of the antioxidant response element (ARE) by the Nrf2
pathway causes the induction of the phase II enzymes (e.g., HO-1,
NQO1, GR, SOD, GCLS and Prx-1). The mRNAs for HO-1, superoxide
dismutase 3 (SOD3), NQO1 and γ-glutamate cysteine ligase subunit
(GCLS) were increased in RAW 264.7 cells treated with desoxyrha-
pontigenin, whereas SOD2, glutathione reductase (GR) and Prx-
1 mRNA levels were unchanged (Fig. 3A). Western blot analysis was
conducted to conﬁrm the induction of HO-1 protein expression by
desoxyrhapontigenin (Fig. 3B).
Desoxyrhapontigenin increased the levels of the Nrf2 transcription
factor and reduced the expression of Keap1
Most of the genes encoding phase II detoxifying and antioxidant
enzymes have an ARE sequence in their promoter regions. Nrf2 is
an important transcription factor that regulates the ARE-driven
expression of proteins such as HO-1 and other phase II enzymes.
Fig. 2. Effects of stilbene derivatives on intracellular ROS and peroxynitrite, The effects of stilbene compounds on t-BHP-induced ROS (A) and peroxynitrite (B) generation in
RAW 264.7 cells were evaluated. Desoxyrhapontigenin and resveratrol had dose-dependent inhibitory effects on t-BHP-induced ROS and peroxynitrite levels. The data were
obtained from three independent experiments and are expressed as the means7S.D. In this ﬁgure, (n), (nn) and (nnn) indicate a signiﬁcant difference from the t-BHP-
induced group at the Po0.05, Po0.01 and Po0.001 levels, respectively, whereas (###) indicates a signiﬁcant difference from the unstimulated control group at the Po0.01
level. Quercetin was used as a positive control.
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Desoxyrhapontigenin treatment increased both phosphorylated
Nrf2 and Nrf2 accumulation in the nuclear fraction (Fig. 4A).
Moreover, desoxyrhapontigenin down-regulated the expression of
the Keap1 protein, an inhibitor of Nrf2, in a time-dependent
manner (Fig. 4B). To determine the role of Nrf2 in the transcrip-
tional activation of ARE, an EMSA was performed. Desoxyrhaponti-
genin increased Nrf2 binding to the ARE sequence (Fig. 4C).
Induction of HO-1 and activation of Nrf2 by desoxyrhapontigenin via
the PI3K/Akt pathway
To elucidate the upstream signaling pathway involved in
desoxyrhapontigenin-mediated Nrf2 activation and HO-1 induc-
tion, speciﬁc inhibitors of PI3K/Akt (LY294002), p38 (SB202190),
JNK (SP600125) and ERK (U0126) were used. Inhibition of the Akt
pathway reduced the capacity of desoxyrhapontigenin to induce
increased HO-1 protein levels (Fig. 5A). To conﬁrm these results,
cells were transfected with siNrf2 or siAkt and treated with
desoxyrhapontigenin. Activation of Nrf2 by desoxyrhapontigenin
was inhibited in siAkt or siNrf-transfected cells, and HO-1 induc-
tion was inhibited in siNrf2-transfected cells (Fig. 5B).
Effects of desoxyrhapontigenin in a mouse model of LPS-induced
inﬂammatory lung injury
Lung tissues were collected 24 h after injection with LPS and
subjected to H and E staining and immunohistochemistry (Fig. 6).
The inﬂammation was reduced by desoxyrhapontigenin treatment
as visualized by H and E staining. The thickened alveolar septal
wall induced by LPS was reduced in the desoxyrhapontigenin-
treated groups. Furthermore, desoxyrhapontigenin reduced neu-
trophil inﬁltration and alveolar hemorrhage (Fig. 6A). Immuno-
histochemical analysis of Nrf2 and HO-1 was performed to conﬁrm
that treatment with desoxyrhapontigenin induced Nrf2 (Fig. 6C)
and HO-1 (Fig. 6B) expression. The Nrf2 or HO-1 protein was
distributed in the desoxyrhapontigenin-treated lung tissues,
stained as brown granules or dots. In contrast, in the NF-κBp65-
immunostained lung sections, desoxyrhapontigenin suppressed
Fig. 3. Effects of desoxyrhapontigenin on the mRNA expression of antioxidant enzymes and the protein expression of HO-1, RAW 264.7 cells were treated with 50 μM
desoxyrhapontigenin. Reverse transcription and real-time PCR analyses are described in “Section 2”. The relative phase II enzyme expression levels (in terms of 2ΔCt) were
determined by real-time PCR and calculated by subtracting the Ct value for β-actin from the Ct values for the phase II enzymes (ΔCt¼Ct(antioxidant)Ct(β-actin)) (A). Western blot
analysis was conducted to conﬁrm the time-course of HO-1 protein expression induction by desoxyrhapontigenin. The cells were treated with desoxyrhapontigenin at 50 μM
for the indicated time periods, and the total proteins were extracted to detect the expression of HO-1 (B).
Fig. 4. Effects of desoxyrhapontigenin on the protein expression levels of Nrf2, p-Nrf2 and Keap1 and the transcriptional activity of the ARE in RAW 264.7 macrophages,
Nuclear and cytoplasmic extracts from RAW 264.7 cells were prepared after treatment with desoxyrhapontigenin at 50 μM for the indicated time periods (A). Total protein
extracts from the speciﬁed time periods were also prepared for detecting Keap1, an inhibitor of Nrf2 (B). To conﬁrm the speciﬁc DNA–protein interaction, an EMSA was
performed with excess amounts of unlabeled Nrf2 oligonucleotide in a competition assay (Cold) (C).
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p65 expression when compared with the LPS-treated group
(Fig. 6D).
Molecular docking study
LigandFit employs a shape comparison ﬁlter and Monte Carlo
conformational analysis for generating poses consistent with the
active site shape. The binding afﬁnities were calculated with the
LigScore scoring function, yielding a DOCK_SCORE value of 50.715
for desoxyrhapontigenin. However, LigandFit could not match
resveratrol to the site or produce any poses. Desoxyrhapontigenin
forms hydrogen bonds with Arg415, Val418, Cys368 and Val606.
Discussion
Oxidative stress is deﬁned as an imbalance between the produc-
tion of free radicals and their elimination by cellular defense
mechanisms. ROS are chemically reactive molecules containing
oxygen and are produced by normal cellular metabolism. Generated
ROS in mitochondria and cells cause damage to lipids, proteins and
DNA [36]. To protect against produced ROS, such as superoxide
anion (O2), hydrogen peroxide (H2O2), hydroxyl radical (OH) and
organic peroxides, cellular antioxidant enzymes including super-
oxide dismutase, catalase and glutathione peroxidase are induced.
In addition to ROS, reactive nitrogen species (RNS) are molecules
derived from nitric oxide (NO) and superoxide (O2). Neither NO
nor O2 is toxic in vivo but powerful oxidant peroxynitrite (ONOO–)
is formed by the reaction of NO and O2. Excessive production of
peroxynitrite causes tissue damage or cell death and is involved in
the pathophysiology of cardiovascular diseases, neurodegenerative
disorders, local inﬂammation, diabetes and cancer [37].
Nrf2 is a transcription factor that induces antioxidant and phase II
detoxifying enzymes that combat ROS or RNS. The promoters of
cytoprotective proteins contain a speciﬁc consensus sequence called
the ARE to which Nrf2 binds, promoting the transcription of ARE-
related genes. Recent studies have reported that Nrf2-related ARE
signaling is involved in attenuating inﬂammation-associated diseases
[6]. During the early phase of inﬂammation-mediated tissue damage,
activation of Nrf2-ARE may inhibit the production or expression of
pro-inﬂammatory mediators including cytokines, COX-2 and iNOS. It is
likely that the cytoprotective function of genes targeted by Nrf2 may
cooperatively regulate the innate immune response and also repress
the induction of pro-inﬂammatory genes. Polyphenolic compounds
have been studied with respect to their antioxidative effects and
ability to scavenge free radicals [38]. Resveratrol, a polyphenolic
stilbene compound, has been shown to possess antioxidative, anti-
inﬂammatory and anticancer effects [12,39,40].
Inﬂammation and oxidative stress are closely related. The key
transcription factors Nrf2, NF-κB and AP-1 are essential, because
the induction of Nrf2 leads to the up-regulation of antioxidant
proteins and enzymes, whereas the inhibition of NF-κB and AP-1
blocks inﬂammatory mediators [41]. Previous studies have
demonstrated that resveratrol inhibits the activities of NF-κB
and AP-1 and induces detoxiﬁcation and antioxidant enzymes
through the Nrf2 pathway [41]. Thus, the hypothesis has been
proposed in the present study that other stilbene components may
act similarly and exhibit anti-inﬂammatory and antioxidative
properties.
In this study, six stilbene derivatives from R. undulatum L. were
assessed for their antioxidative properties. As expected, desoxyrha-
pontigenin and resveratrol reduced stimulated ROS and peroxyni-
trite levels. However, resveratrol caused cytotoxic effects at higher
concentrations in RAW 264.7 macrophages while desoxyrhaponti-
genin showed no signiﬁcant cytotoxicity (Fig. 2). Because desoxyr-
hapontigenin exhibited promising inhibitory effects on excessive
ROS and peroxynitrite levels in the t-BHP-induced RAW 264.7
macrophage cell line, real-time PCR analysis was conducted to
determine which of the phase II enzymes are induced by deso-
xyrhapontigenin. The phase II enzymes (e.g., HO-1, NQO1, GR, SOD,
GCLS and Prx-1) are induced by activation of the ARE by the Nrf2
pathway. Desoxyrhapontigenin up-regulated the mRNA expression
of HO-1, SOD3, NQO1 and GCLS, which are all transcribed by
increased binding to the ARE (Fig. 3). Indeed, desoxyrhapontigenin
induced HO-1 expression by targeting the ARE sequence, and this
ﬁnding was supported by Nrf2 accumulation in the nucleus (Fig. 4).
The increase in ARE-driven gene expression through Nrf2 activation
may be regulated by two mechanisms [41].
In the ﬁrst possible mechanism, Nrf2 is phosphorylated through
kinase signaling pathways and translocates to the nucleus to bind
Fig. 5. Effects of speciﬁc inhibitors on the induction of HO-1 by desoxyrhapontigenin and the effects of siAkt and siNrf2 on the induction of Nrf2 and HO-1 by
desoxyrhapontigenin, To elucidate the upstream signaling pathway involved in desoxyrhapontigenin-mediated Nrf2 activation and HO-1 induction, speciﬁc inhibitors of
PI3K/Akt (LY294002), p38 (SB202190), JNK (SP600125) and ERK (U0126) were used. Inhibition of the Akt pathway reduced the capacity of desoxyrhapontigenin to induce
HO-1 protein (A). To conﬁrm these ﬁndings, cells were transfected with siNrf2 or siAkt and treated with desoxyrhapontigenin. Activation of Nrf2 by desoxyrhapontigenin
was inhibited in siAkt or siNrf-transfected cells, and HO-1 induction was inhibited in siNrf2-transfected cells (B). The results of three experiments are expressed as the
means7S.D. Signiﬁcant differences from the desoxyrhapotigenin only-treated group are shown by (n) and (nn) which indicate the Po0.05 and Po0.01 levels, respectively.
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to the ARE. When the PI3K, PKC or MAPK signaling pathways are
activated, phosphorylated Nrf2 can be liberated from Keap1. Signaling
pathways that are involved in the activation of Nrf2-mediated gene
expression can be elucidated by using speciﬁc kinase inhibitors. Thus,
desoxyrhapontigenin-mediated HO-1 induction was inhibited by
chemical inhibitors of kinases such as PI3K/Akt (LY294002), p38
(SB202190), JNK (SP600125) and ERK (U0126). These inhibitors block
the phosphorylation of kinases accordingly, thus the PI3K/Akt, p38,
JNK or ERK signaling pathway may be hampered. Treatment with
LY294002 blocked desoxyrhapontigenin-induced HO-1 up-regulation,
whereas the blockage of other signaling pathways was unrelated. It
seems that the activation of the PI3K/Akt pathway is closely correlated
with HO-1 expression. RNA interference of the Akt or Nrf2 genes
supports the hypothesis that desoxyrhapontigenin-induced ARE-dri-
ven genes, particularly HO-1, are stimulated by Nrf2 activation, which
is regulated by the activation of Akt signaling (Fig. 5).
Another possible mechanism of Nrf2 activation involves the
cysteine residues of the Keap1 protein [42]. Keap1 has 25 cysteine
residues, which make Keap1 an attractive target for thiol-reactive
chemical species. Thus, inactivation of Keap1 is suggested to be
another mechanism for Nrf2 activation. Modifying reactive cysteine
residues by antioxidants abrogates the repressor activity of Keap1
and releases Nrf2 from the Keap1 complex. Sulforaphane is a potent
natural product-derived Nrf2 activator that functions by modifying
Keap1 cysteine residues. The C151, C38, C368 and C489 residues of
Keap1 are the most readily modiﬁed by the phytochemical sulfor-
aphane [43]. Molecular docking analysis was performed with
desoxyrhapontigenin to assess its possible binding sites to Keap1
protein in this study. The results revealed that desoxyrhapontigenin
forms hydrogen bonds with Arg 415, Val 418, Cys 368 and Val 606.
This bonding could contribute to the activation of Nrf2 by deso-
xyrhapontigenin by inhibiting Keap1 repressor activity (Fig. 7).
In response to bacterial infection, the innate immune system is
initiated for host defense. LPS-induced endotoxic shock or sepsis is
characterized by severe tissue damage and the inﬁltration of
neutrophils and macrophages into the lungs. During sepsis, Nrf2 is
one of the most critical regulators that protect against inﬂammatory
processes. Nrf2-deﬁcient mouse models have been widely used to
demonstrate the pivotal role of Nrf2 in LPS-induced pulmonary
inﬂammation. NADPH oxidase-dependent ROS are closely involved
in the pathophysiology of sepsis because disruption of the NADPH
oxidase subunit gp91phox in Nrf2-deﬁcient mice signiﬁcantly
reduced LPS-induced systemic and lung inﬂammation [44]. Studies
suggest that Nrf2-mediated cellular antioxidants are crucial modi-
ﬁers of the pathogenesis of sepsis [45]. In addition to cecal ligation
and puncture (CLP), which is a clinically relevant model of sepsis,
challenge with LPS induced higher lethality in Nrf2-deﬁcient mice
than in wild-type mice. Moreover, sepsis and septic shock by
induced LPS resulted in severe lung inﬂammation in Nrf2-
deﬁcient mice through the TLR4 signaling pathway. Because NF-
κB is a major regulator of the TLR4 signaling pathway, NF-κB-
mediated proinﬂammatory genes were up-regulated when Nrf2
was knocked out [46]. Thus, molecules that increase Nrf2 activity
can be protective against the LPS-induced inﬂammatory response
[47]. For instance, herbal medicines known as anti-inﬂammatory
agents also show protective effects against LPS-induced lung
inﬂammation through Nrf2 activation [48,49].
Fig. 6. Histological changes of desoxyrhapontigenin treatment in LPS-induced lung
inﬂammation and immunohistochemistry analysis of Nrf2, HO-1 and p65, Lung
tissues were collected at 24 h after injection of LPS and subjected to H and E
staining and immunohistochemistry (200). The alveolar septal wall was thick-
ened (a brace) and destroyed by prominent neutrophil inﬁltration (arrows) and
alveolar hemorrhage in the LPS-treated group. Desoxyrhapontigenin treatment
reduced neutrophil inﬁltration and alveolar hemorrhage, whereas the thickened
alveolar septal wall returned to normal (A). Photomicrographs of the HO-1, Nrf2
and p65-immunostained lung sections conﬁrmed that desoxyrhapontigenin
induces HO-1 (B) and Nrf2 (C), but reduces p65 (D) in LPS-treated lung tissues
(brown dots). The sections were quantiﬁed by ImageJ version1.46r software (E). The
results are expressed as the means7S.D. Signiﬁcant differences from the LPS-
treated group are shown by (n), (nn) and (nn) which indicate the Po0.05, Po0.01
and Po0.001 levels, respectively.
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Because desoxyrhapontigenin was investigated for its antioxidative
properties in RAW 264.7 cells, the LPS-treated mouse model was used
to further verify its effects. In preliminary studies, the proper doses of
desoxyrhapontigenin were selected that could attenuate LPS-induced
acute lung injury (data not shown). After i.p. administration of LPS
resulted in macrophage inﬁltration, alveolar septal thickening and
alveolar hemorrhage in lung tissues, administration of desoxyrhapon-
tigenin signiﬁcantly reduced these inﬂammation-mediated histologi-
cal changes. Up-regulation of Nrf2 and HO-1 expression by desoxy-
rhapontigenin was also observed in lung tissue extracts, whereas p65
expression was reduced. Therefore, the effects of desoxyrhapontigenin
were due to the induction of Nrf2-mediated HO-1 but inhibition of
NF-κB.
Conclusions
In the t-BHP-induced RAW 264.7 macrophage cell line, deso-
xyrhapontigenin decreased ROS and peroxynitrite production.
Desoxyrhapontigenin itself induced phase II detoxifying genes,
particularly HO-1. The induction of HO-1 by desoxyrhapontigenin
was due to the activation of Nrf2 and the inhibition of KEAP1 via
the Akt pathway, as conﬁrmed by speciﬁc inhibitors and RNA
interference techniques. Moreover, desoxyrhapontigenin amelio-
rated endotoxin-induced lung inﬂammation by the up-regulation
of HO-1 and Nrf2 and the simultaneous inhibition of p65 expres-
sion. Taken together, desoxyrhapontigenin is a new candidate anti-
inﬂammatory or antioxidative agent.
Acknowledgments
This work was supported by grants (NRF-2013R1A1A2A10005492
and MRC-2009-93146) from the National Research Foundation of
Korea.
References
[1] P. Moi, K. Chan, I. Asunis, A. Cao, Y.W. Kan, Isolation of NF-E2-related factor 2
(Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to
the tandem NF-E2/AP1 repeat of the beta-globin locus control region, Proc.
Natl. Acad. Sci. USA 91 (1994) 9926–9930.
[2] J.M. Lee, J.A. Johnson, An important role of Nrf2-ARE pathway in the cellular
defense mechanism, J. Biochem. Mol. Biol. 37 (2004) 139–143.
[3] T. Nguyen, P. Nioi, C.B. Pickett, The Nrf2-antioxidant response element signaling
pathway and its activation by oxidative stress, J. Biol. Chem. 284 (2009)
13291–13295.
[4] R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, S. Biswal,
Identiﬁcation of Nrf2-regulated genes induced by the chemopreventive agent
sulforaphane by oligonucleotide microarray, Cancer Res. 62 (2002) 5196–5203.
[5] J. Alam, D. Stewart, C. Touchard, S. Boinapally, A.M. Choi, J.L. Cook, Nrf2, a
Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1
gene, J. Biol. Chem. 274 (1999) 26071–26078.
[6] J. Kim, Y.N. Cha, Y.J. Surh, A protective role of nuclear factor-erythroid 2-related
factor-2 (Nrf2) in inﬂammatory disorders, Mutat. Res. 690 (2010) 12–23.
[7] S.W. Ryter, R.M. Tyrrell, The heme synthesis and degradation pathways: role in
oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties,
Free Radic. Biol. Med. 28 (2000) 289–309.
[8] M.H. Kapturczak, C. Wasserfall, T. Brusko, M. Campbell-Thompson, T.M. Ellis,
M.A. Atkinson, A. Agarwal, Heme oxygenase-1 modulates early inﬂammatory
responses: evidence from the heme oxygenase-1-deﬁcient mouse, Am. J.
Pathol. 165 (2004) 1045–1053.
[9] W. Li, T.O. Khor, C. Xu, G. Shen, W.S. Jeong, S. Yu, A.N. Kong, Activation of Nrf2-
antioxidant signaling attenuates NF-kappaB-inﬂammatory response and eli-
cits apoptosis, Biochem. Pharmacol. 76 (2008) 1485–1489.
[10] W. Jin, H. Wang, W. Yan, L. Xu, X. Wang, X. Zhao, X. Yang, G. Chen, Y. Ji,
Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity,
proinﬂammatory cytokines, and intercellular adhesion molecule-1 in the brain
after traumatic brain injury, Mediators Inﬂamm. 2008 (2008) 725174.
[11] G.H. Liu, J. Qu, X. Shen, NF-kappaB/p65 antagonizes Nrf2-ARE pathway by
depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK,
Biochim. Biophys. Acta 1783 (2008) 713–727.
[12] M. Lee, S. Kim, O.K. Kwon, S.R. Oh, H.K. Lee, K. Ahn, Anti-inﬂammatory and
anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse
model of allergic asthma, Int. Immunopharmacol. 9 (2009) 418–424.
[13] J.K. Kundu, Y.J. Surh, Cancer chemopreventive and therapeutic potential of
resveratrol: mechanistic perspectives, Cancer Lett. 269 (2008) 243–261.
[14] M. Campagna, C. Rivas, Antiviral activity of resveratrol, Biochem. Soc. Trans. 38
(2010) 50–53.
[15] E.S. Choi, S.D. Cho, J.G. Jeon, N.P. Cho, The apoptotic effect of the hexane extract
of Rheum undulatum L. in Oral cancer cells through the down-regulation of
speciﬁcity protein 1 and survivin, Lab. Anim. Res 27 (2011) 19–24.
[16] J.E. Kim, H.J. Kim, S. Pandit, K.W. Chang, J.G. Jeon, Inhibitory effect of a
bioactivity-guided fraction from Rheum undulatum on the acid production
of Streptococcus mutans bioﬁlms at sub-MIC levels, Fitoterapia 82 (2011)
352–356.
[17] J.H. Song, T.C. Yang, K.W. Chang, S.K. Han, H.K. Yi, J.G. Jeon, In vitro anti-
cariogenic activity of dichloromethane fraction from Rheum undulatum L. root,
Arch. Pharm. Res. 29 (2006) 490–496.
Fig. 7. Binding modes of desoxyrhapontigenin within the protein active site of KEAP1 in the molecular docking study, The ligand is displayed in a ball-and-stick style in
a cyan color, and the protein is displayed as line ribbon. Desoxyrhapontigenin forms hydrogen bonds with Arg 415, Val 418, Cys 368 and Val 606 of KEAP1.
R. Joo Choi et al. / Redox Biology 2 (2014) 504–512 511
[18] S.Z. Choi, S.O. Lee, K.U. Jang, S.H. Chung, S.H. Park, H.C. Kang, E.Y. Yang, H.J. Cho,
K.R. Lee, Antidiabetic stilbene and anthraquinone derivatives from Rheum
undulatum., Arch. Pharm. Res. 28 (2005) 1027–1030.
[19] W. Lee, G. Yoon, Y.R. Hwang, Y.K. Kim, S.N. Kim, Anti-obesity and hypolipi-
demic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through
protein tyrosine phosphatase 1B inhibition, BMB Rep 45 (2012) 141–146.
[20] D.H. Kim, E.K. Park, E.A. Bae, M.J. Han, Metabolism of rhaponticin and
chrysophanol 8-O-β-D-glucopyranoside from the rhizome of Rheum undula-
tum by human intestinal bacteria and their anti-allergic actions, Biol. Pharm.
Bull. 23 (2000) 830–833.
[21] J.H. Lee, J.M. Kim, C. Kim, Pharmacokinetic analysis of rhein in Rheum
undulatum L, J. Ethnopharmacol. 84 (2003) 5–9.
[22] R.J. Choi, J. Chun, S. Khan, Y.S. Kim, Desoxyrhapontigenin, a potent anti-
inﬂammatory phytochemical, inhibits LPS-induced inﬂammatory responses
via suppressing NF-kappaB and MAPK pathways in RAW 264.7 cells, Int.
Immunopharmacol. 18 (2013) 182–190.
[23] T. Perecko, V. Jancinova, K. Drabikova, R. Nosal, J. Harmatha, Structure-
efﬁciency relationship in derivatives of stilbene. Comparison of resveratrol,
pinosylvin and pterostilbene, Neuro. Endocrinol. Lett. 29 (2008) 802–805.
[24] A.H. Hasiah, A.R. Ghazali, J.F. Weber, S. Velu, N.F. Thomas, S.H. Inayat Hussain,
Cytotoxic and antioxidant effects of methoxylated stilbene analogues on
HepG2 hepatoma and Chang liver cells: Implications for structure activity
relationship, Hum. Exp. Toxicol. 30 (2011) 138–144.
[25] T. Coppa, M.C. Lazze, O. Cazzalini, P. Perucca, R. Pizzala, L. Bianchi, L.A. Stivala,
L. Forti, C. Maccario, V. Vannini, M. Savio, Structure-activity relationship of
resveratrol and its analogue, 4,4'-dihydroxy-trans-stilbene, toward the
endothelin axis in human endothelial cells, J. Med. Food 14 (2011) 1173–1180.
[26] C. VanMen, Y.S. Jang, H.M. Zhu, J.H. Lee, T.N. Trung, T.M. Ngoc, Y.H. Kim,
J.S. Kang, Chemical-based species classiﬁcation of rhubarb using simultaneous
determination of ﬁve bioactive substances by HPLC and LDA analysis,
Phytochem. Anal. 23 (2012) 359–364.
[27] T.M. Ngoc, P.T. Minh, T.M. Hung, P.T. Thuong, I. Lee, B.S. Min, K. Bae,
Lipoxygenase inhibitory constituents from rhubarb, Arch. Pharm. Res. 31
(2008) 598–605.
[28] K.L. Wolfe, R.H. Liu, Cellular antioxidant activity (CAA) assay for assessing
antioxidants, foods, and dietary supplements, J. Agric. Food Chem. 55 (2007)
8896–8907.
[29] N.W. Kooy, J.A. Royall, H. Ischiropoulos, J.S. Beckman, Peroxynitrite-mediated
oxidation of dihydrorhodamine 123, Free Radic. Biol. Med. 16 (1994) 149–156.
[30] E.M. Shin, S. Kim, I. Merfort, Y.S. Kim, Glycyrol induces apoptosis in human
Jurkat T cell lymphocytes via the Fas-FasL/caspase-8 pathway, Planta Med. 77
(2011) 242–247.
[31] N. Li, J. Alam, M.I. Venkatesan, A. Eiguren-Fernandez, D. Schmitz, E. Di Stefano,
N. Slaughter, E. Killeen, X. Wang, A. Huang, M. Wang, A.H. Miguel, A. Cho,
C. Sioutas, A.E. Nel, Nrf2 is a key transcription factor that regulates antioxidant
defense in macrophages and epithelial cells: protecting against the proin-
ﬂammatory and oxidizing effects of diesel exhaust chemicals, J. Immunol. 173
(2004) 3467–3481.
[32] H.H. Chen, Y.T. Chen, Y.W. Huang, H.J. Tsai, C.C. Kuo, 4-Ketopinoresinol, a novel
naturally occurring ARE activator, induces the Nrf2/HO-1 axis and protects
against oxidative stress-induced cell injury via activation of PI3K/AKT signaling,
Free Radic. Biol. Med. 52 (2012) 1054–1066.
[33] U. Zabel, R. Schreck, P.A. Baeuerle, DNA binding of puriﬁed transcription factor
NF-kappa B. Afﬁnity, speciﬁcity, Zn2þ dependence, and differential half-site
recognition, J. Biol. Chem. 266 (1991) 252–260.
[34] T.I. Weng, H.Y. Wu, C.W. Kuo, S.H. Liu, Honokiol rescues sepsis-associated
acute lung injury and lethality via the inhibition of oxidative stress and
inﬂammation, Intensive Care Med. 37 (2011) 533–541.
[35] L.J. Beamer, X. Li, C.A. Bottoms, M. Hannink, Conserved solvent and side-chain
interactions in the 1.35 Angstrom structure of the Kelch domain of Keap1, Acta
Crystallogr. D Biol. Crystallogr. 61 (2005) 1335–1342.
[36] B.A. Freeman, J.D. Crapo, Biology of disease: free radicals and tissue injury, Lab.
Invest. 47 (1982) 412–426.
[37] P. Pacher, J.S. Beckman, L. Liaudet, Nitric oxide and peroxynitrite in health and
disease, Physiol. Rev. 87 (2007) 315–424.
[38] H. Erlank, A. Elmann, R. Kohen, J. Kanner, Polyphenols activate Nrf2 in
astrocytes via H2O2, semiquinones, and quinones, Free Radic. Biol. Med. 51
(2011) 2319–2327.
[39] A.N. Kong, R. Yu, V. Hebbar, C. Chen, E. Owuor, R. Hu, R. Ee, S. Mandlekar,
Signal transduction events elicited by cancer prevention compounds, Mutat.
Res. 480–481 (2001) 231–241.
[40] J. Ren, C. Fan, N. Chen, J. Huang, Q. Yang, Resveratrol pretreatment attenuates
cerebral ischemic injury by upregulating expression of transcription factor
Nrf2 and HO-1 in rats, Neurochem. Res. 36 (2011) 2352–2362.
[41] G.X. Shen, W.S. Jeong, R. Hu, A.N. T. Kong, Regulation of Nrf2, NF-kappa B, and
AP-1 signaling pathways by chemopreventive agents, Antioxid. Redox Sign 7
(2005) 1648–1663.
[42] N. Wakabayashi, A.T. Dinkova-Kostova, W.D. Holtzclaw, M.I. Kang,
A. Kobayashi, M. Yamamoto, T.W. Kensler, P. Talalay, Protection against
electrophile and oxidant stress by induction of the phase 2 response: fate of
cysteines of the Keap1 sensor modiﬁed by inducers, Proc. Natl. Acad. Sci. USA
101 (2004) 2040–2045.
[43] C. Hu, A.L. Eggler, A.D. Mesecar, R.B. van Breemen, Modiﬁcation of keap1
cysteine residues by sulforaphane, Chem. Res. Toxicol. 24 (2011) 515–521.
[44] X. Kong, R. Thimmulappa, P. Kombairaju, S. Biswal, NADPH oxidase-dependent
reactive oxygen species mediate ampliﬁed TLR4 signaling and sepsis-induced
mortality in Nrf2-deﬁcient mice, J. Immunol. 185 (2010) 569–577.
[45] K.R. Sekhar, P.A. Crooks, V.N. Sonar, D.B. Friedman, J.Y. Chan, M.J. Meredith,
J.H. Starnes, K.R. Kelton, S.R. Summar, S. Sasi, M.L. Freeman, NADPH oxidase
activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to
2-indol-3-yl-methylenequinuclidin-3-ols, Cancer Res. 63 (2003) 5636–5645.
[46] R.K. Thimmulappa, H. Lee, T. Rangasamy, S.P. Reddy, M. Yamamoto,
T.W. Kensler, S. Biswal, Nrf2 is a critical regulator of the innate immune
response and survival during experimental sepsis, J. Clin. Invest. 116 (2006)
984–995.
[47] R.K. Thimmulappa, C. Scollick, K. Traore, M. Yates, M.A. Trush, K.T. Liby,
M.B. Sporn, M. Yamamoto, T.W. Kensler, S. Biswal, Nrf2-dependent protection
from LPS induced inﬂammatory response and mortality by CDDO-Imidazolide,
Biochem. Biophys. Res. Commun. 351 (2006) 883–889.
[48] H.J. Park, B.T. Jeon, H.C. Kim, G.S. Roh, J.H. Shin, N.J. Sung, J. Han, D. Kang, Aged
red garlic extract reduces lipopolysaccharide-induced nitric oxide production
in RAW 264.7 macrophages and acute pulmonary inﬂammation through
haeme oxygenase-1 induction, Acta Physiol. (Oxf) 205 (2012) 61–70.
[49] J.Y. Choi, M.J. Kwun, K.H. Kim, J.H. Lyu, C.W. Han, H.S. Jeong, K.T. Ha, H.J. Jung,
B.J. Lee, R.T. Sadikot, J.W. Christman, S.K. Jung, M. Joo, Protective effect of the
fruit hull of Gleditsia sinensis on LPS-induced acute lung injury is associated
with Nrf2 activation, Evid. Based. Complement. Alternat. Med. 2012 (2012)
974713 http://dx.doi.org/10.1155/2012/974713.
R. Joo Choi et al. / Redox Biology 2 (2014) 504–512512
